Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 52, Issue 6, Pages 1066-1079
Publisher
Informa UK Limited
Online
2011-05-23
DOI
10.3109/10428194.2011.562570
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer stem cells: Models, mechanisms and implications for improved treatment
- (2011) Jiangbing Zhou et al. CELL CYCLE
- DNA damage, neuronal and glial cell death and neurodegeneration
- (2010) Ari Barzilai APOPTOSIS
- CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance
- (2010) Amit S. Adhikari et al. CANCER RESEARCH
- Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells
- (2010) Patrizia Cammareri et al. CANCER RESEARCH
- Cancer stem cells and chemoradiation resistance
- (2010) Hideshi Ishii et al. CANCER SCIENCE
- Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities
- (2010) Gigi Chiu et al. CURRENT DRUG METABOLISM
- Lymphoma stem cells: enough evidence to support their existence?
- (2010) J. A. Martinez-Climent et al. HAEMATOLOGICA
- Targeting Breast Cancer Stem Cells
- (2010) Suling Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Mantle cell lymphoma: state-of-the-art management and future perspective
- (2010) Oliver Weigert et al. LEUKEMIA & LYMPHOMA
- Prospective isolation of clonogenic mantle cell lymphoma-initiating cells
- (2010) Zheng Chen et al. Stem Cell Research
- CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133− cells
- (2010) Mónica Enguita-Germán et al. TUMOR BIOLOGY
- How I treat mantle cell lymphoma
- (2009) M. Ghielmini et al. BLOOD
- Molecular biology of mantle cell lymphoma: From profiling studies to new therapeutic strategies
- (2009) Antònia Obrador-Hevia et al. BLOOD REVIEWS
- Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells
- (2009) Masayoshi Kobune et al. CANCER SCIENCE
- Ten years of rituximab in NHL
- (2009) Matthew C Winter et al. Expert Opinion On Drug Safety
- Mantle cell lymphoma
- (2009) S. A. Pileri et al. HAEMATOLOGICA
- Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children
- (2009) Hiroaki Goto et al. LEUKEMIA RESEARCH
- Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
- (2009) Tristan M. Sissung et al. MOLECULAR BIOTECHNOLOGY
- Current treatment standards and emerging strategies in mantle cell lymphoma
- (2009) M. Dreyling et al. Hematology-American Society of Hematology Education Program
- Advances in the understanding of mantle cell lymphoma
- (2008) Pedro Jares et al. BRITISH JOURNAL OF HAEMATOLOGY
- Therapy of Mantle Cell Lymphoma: Current Standards and Future Strategies
- (2008) Christian Schmidt et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy
- (2008) X. Zhou et al. ONCOLOGIST
- Mantle cell lymphoma: Frontline and salvage therapy
- (2008) Jorge E. Romaguera Current Hematologic Malignancy Reports
- What of apoptosis is important: The decay process or the causative origin?
- (2007) Ger P.A. Bongaerts MEDICAL HYPOTHESES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now